NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India’s Food Fortification Landscape
THANJAVUR, India, July 10, 2025 /PRNewswire/ -- Fermenta Biotech Limited ("Fermenta"), a pioneer…
Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class…
AN Venture Partners Announces Final Close of $200M Fund I
One of the largest Japan focused biotech funds to dateSAN FRANCISCO &…
SINOVAC Board of Directors Prevails Against Advantech/Primes New York Lawsuit
New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal…
Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia has concluded its…
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech…
Kane Biotech Provides Further Corporate Update
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE)…
Prime Success Responds to Sinovac Biotechs False and Misleading Claims
For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its…
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading…